Cocrystal Pharma, Inc. Common Stock

€0.98917
EUR
Last updated on --.
24h volume1.30K
24h highest1.0003 EUR
24h lowest0.97112 EUR
24h Price movement+1.86%

COCP recent prices

24 Hours
+1.86%+€0.018047
30 days
-18.57%-€0.22344
60 days
+12.62%+€0.11172
90 days
+7.55%+€0.068752

Key data

Previous close0.97112 EUR
Market cap13.15M EUR
Volume1.30K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.55002 EUR
Net income (FY)-7.59M EUR
Revenue (FY)193.37K EUR
Last report dateMay 15, 2026

About Cocrystal Pharma, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersBOTHELL
Employees (FY)10.00
Revenue per employee (FY)19.34K EUR
Net income per employee (FY)-758.76K EUR
Listed onNasdaq
Official website

COCP conversion tables

COCPCOCP
EUREUR
0.5 COCP0.49458 EUR
1 COCP0.98917 EUR
5 COCP4.945 EUR
10 COCP9.891 EUR
EUREUR
COCPCOCP
0.5 EUR0.50547 COCP
1 EUR1.010 COCP
5 EUR5.054 COCP
10 EUR10.1 COCP

FAQ

COCP is trading at €0.98917, +1.86% over the last 24 hours. Track live moves on the price chart at the top of this page.
The COCP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. COCP is currently trading at €0.98917, +1.86% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on COCP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. COCP's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from COCP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against COCP's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Cocrystal Pharma, Inc. Common Stock's market cap is currently 13.15M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.30K
24h highest1.0003 EUR
24h lowest0.97112 EUR
24h Price movement+1.86%
COCPCOCP
EUREUR
Start trade with COCP Perpetual